Aromatase activity modulation by lindane and bisphenol-A in human placental JEG-3 and transfected kidney E293 cells

Toxicology in Vitro

Volumn 17, Issue 4, 2003, Pages 413-422

  Nativelle Serpentini, C ^a,b   Richard, S ^a   Seralini G E ^a   Sourdaine, P ^a  

^a UNIVERSITÉ DE CAEN   (France)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Cytochrome P 450, aromatase; Enzyme modulation; Xenobiotics

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; AROMATASE; CYTOCHROME P450; LINDANE; MESSENGER RNA;

ARTICLE; CELL LINE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOTOXICITY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INCUBATION TIME; KIDNEY CELL; MODULATION; PLACENTA; TIME;

ANIMALIA;

EID: 0038094396     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-2333(03)00046-8     Document Type: Article

References (62)

1. Auvray P., Sourdaine P., Seralini G.-E. PAAn-1b and PAAn-E: two phosphorothioate antisense oligodeoxynucleotides inhibit human aromatase gene expression. Biochemical and Biophysical Research Communications. 253:1998;1-9.
2. Auvray P., Nativelle C., Bureau R., Dallemagne P., Seralini G.-E., Sourdaine P. Study of substrate specificity of human aromatase by site directed mutagenesis. European Journal of Biochemistry. 269:2002;1393-1405.
3. Auvray P., Sourdaine P., Moslemi S., Seralini G.-E., Sonnet P., Enguehard C., Guillon J., Dallemagne P., Bureau R., Rault S. MR 20492 and MR 20494. two indolizinone derivatives that strongly inhibit human aromatase The Journal of Steroid Biochemistry and Molecular Biology. 70:1999;59-71.
4. Boussif O., Lezoualc'h F., Zanta M.A., Mergny M.D., Scherman D., Demeneix B., Behr J.P. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo. polyethylenimine Proceedings of the National Academy of Sciences of the United States of America. 92:1995;7297-7301.
5. Bradford M.M. A rapid sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry. 72:1976;248-254.
6. Brotons J.A., Olea-Serrano M.F., Villalobos M., Pedraza V., Olea N. Xenoestrogens released from lacquer coatings in food cans. Environmental Health Perspectives. 103:1995;608-612.
7. Chen S., Kao Y.C., Laughton C.A. Binding characteristics of aromatase inhibitors and phytoestrogens to human aromatase. The Journal of Steroid Biochemistry and Molecular Biology. 61:1997;107-115.
8. Chen S., Zhou D., Okubo T., Kao Y.C., Yang C. Breast tumor aromatase. functional role and transcriptional regulation Endocrine-Related Cancer. 6:1999;149-156.
9. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Analytical Biochemistry. 162:1987;156-159.
10. Colborn T., vom Saal F.S., Soto A.M. Developmental effects of endocrine-disrupting chemicals in wildlife and humans. Environmental Health Perspectives. 101:1993;378-384.
11. Conley A., Hinshelwood M. Mammalian aromatases. Reproduction. 121:2001;685-695.
12. Cooper R.L., Chadwick R.W., Rehnberg G.L., Goldman J.M., Booth K.C., Hein J.F., McElroy W.K. Effect of lindane on hormonal control of reproductive function in the female rat. Toxicology and Applied Pharmacology. 99:1989;384-394.
13. Corbin C.J., Graham-Lorence S., McPhaul M., Mason J.I., Mendelson C.R., Simpson E. R Isolation of a full-length cDNA insert encoding human aromatase system cytochrome P-450 and its expression in nonsteroidogenic cells. Proceedings of the National Academy of Sciences of the United States of America. 85:1988;8948-8952.
14. Corbin C.J., Trant J.M., Walters K.W., Conley A.J. Changes in testosterone metabolism associated with the evolution of placental and gonadal isozymes of porcine aromatase cytochrome P450. Endocrinology. 140:1999;5202-5220.
15. Dufort I., Soucy P., Labrie F., Luu-The V. Molecular cloning of human type 3 3 alpha-hydroxysteroid dehydrogenase that differs from 20 alpha-hydroxysteroid dehydrogenase by seven amino acids. Biochemical and Biophysical Research Communications. 228:1996;474-479.
16. Elsby R., Maggs J.L., Ashby J., Park B.K. Comparison of the modulatory effects of human and rat liver microsomal metabolism on the estrogenicity of bisphenol A. implications for extrapolation to humans The Journal of Pharmacology and Experimental Therapeutics. 297:2001;103-113.
17. Giesy J.P., Kannan K., Blankenship A.L., Jones P.D., Hilscherova K. Dioxin-like and non-dioxin-like toxic effects of polychlorinated biphenyls (PCBs). implications for risk assessment European Journal of Public Health. 8:2000;43-45.
18. Gonzalez F.J., Matsunaga T., Nagata K. Structure and regulation of P-450s in the rat P450IIA gene subfamily. Drug Metabolism Reviews. 20:1989;827-837.
19. Hanioka N., Jinno H., Tanaka-Kagawa T., Nishimura T., Ando M. Interaction of bisphenol A with rat hepatic cytochrome P450 enzymes. Chemosphere. 41:2000;973-978.
20. Harada N., Honda S.I., Hatano O. Aromatase inhibitors and enzyme stability. Endocrine-Related Cancer. 6:1999;211-218.
21. Inoue H., Yakota H., Makino T., Yuasa A., Kato S. Bisphenol A glucuronide, a major metabolite in rat bile after liver perfusion. Drug Metabolism and Disposition: the biological fate of chemicals. 29:2001;1084-1087.
22. Jobling S., Reynolds T., White R., Parker M.G., Sumpter J.P. A variety of environmentally persistent chemicals, including some phthalate plasticizers, are weakly estrogenic. Environmental Health Perspectives. 103:1995;582-587.
23. Kanai H., Barrett J.C., Metzler M., Tsutsui T. Cell-transforming activity and estrogenicity of bisphenol-A and 4 of its analogs in mammalian cells. International Journal of Cancer. 93:2001;20-25.
24. Kellis J.T., Vickery L.E. Inhibition of human estrogen synthetase (aromatase) by flavones. Science. 225:1984;1032-1034.
25. Kishida M., McLellan M., Miranda J.A., Callard G.V. Estrogen and xenoestrogens upregulate the brain aromatase isoform (P450aromB) and perturb markers of early development in zebrafish (Danio rerio). Comparative Biochemistry and Physiology. Biochemistry and Molecular Biology. 129:2001;261-268.
26. Kurebayashi H., Harada R., Stewart R.K., Numata H., Ohno Y. Disposition of a low dose of bisphenol A in male and female cynomolgus monkeys. Toxicological Sciences. 68:2002;32-42.
27. Le Bail J.C., Laroche T., Marre-Fournier F., Habrioux G. Aromatase and 17β-hydroxysteroid deshydrogenase inhibition by flavonoids. Cancer Letters. 133:1998;101-106.
28. Lechter R.J., van Holsteijn I., Drenth H.J., Norston R.J., Bergman A., Safe S., Pieters R., van den Berg M. Cytotoxicity and aromatase (CYP19) activity modulation by organochlorines in human placental JEG-3 and JAR choriocarcinoma cells. Toxicology and Applied Pharmacology. 160:1999;10-20.
29. Long B.J., Tilghman S.L., Yue W., Thiantanawat A., Grigoryev D.N., Brodie A.M. The steroidal antiestrogen ICI 182,780 is an inhibitor of cellular aromatase activity. The Journal of Steroid Biochemistry and Molecular Biology. 67:1998;293-304.
30. Maruyama S., Fujimoto N., Yin H., Ito A. Growth stimulation of a rat pituitary cell line MtT/E-2 by environmental estrogens in vitro and in vivo. The Journal of Endocrinology. 46:1999;513-520.
31. Matthews J.B., Twomey K., Zacharewski T.R. In vitro and in vivo interactions of bisphenol A and its metabolite, bisphenol A glucuronide, with estrogen receptor alpha and beta. Chemical Research in Toxicology. 14:2001;149-157.
32. McLachlan J.A., Newbold R.R., Burow M.E., Li S.F. From malformations to molecular mechanisms in the male. three decades of research on endocrine disrupters Acta Pathologica, Microbiologica, et Immunologica Scandinavica. 109:2001;263-272.
33. Miller W.R., Vidya R., Mullen P., Dixon J.M. Induction and suppression of aromatase by inhibitors. Dekker M. Aromatase Inhibition and Breast Cancer. 2001;213-225 Academic Press, London.
34. Monsees T.K., Franz M., Gebhardt S., Winterstein U., Schill W.B., Hayatpour J. Sertoli cells as a target for reproductive hazards. Andrologia. 32:2000;239-246.
35. Morrissey R.E., George J.D., Price C.J., Tyl R.W., Marr M.C., Kimmel C.A. The developmental toxicity of bisphenol A in rats and mice. Fundamental and Applied Toxicology. 8:1987;571-582.
36. Mosmann T. Rapid colorimetric assay for cellular growth and survival. application to proliferation and cytotoxicity assays Journal of Immunological Methods. 65:1983;55-63.
37. Nadal A., Ropero A.B., Laribi O., Maillet M., Fuentes E., Soria B. Nongenomic actions of estrogens and xenoestrogens by binding at a plasma membrane receptor unrelated to estrogen receptor alpha and estrogen receptor beta. Proceedings of the National Academy of Sciences of the United States of America. 97:2000;11603-11608.
38. Nagel S.C., vom Saal F.S., Thayer K.A., Dhar M.G., Boechler M., Welshons W.V. Relative binding affinity-serum modified access (RBA-SMA) assay predicts the relative in vivo bioactivity of the xenoestrogens bisphenol A and octylphenol. Environmental Health perspectives. 105:1997;70-76.
39. Nelson D.R. Metazoan cytochrome P450 evolution. Comparative Biochemistry and Physiology. Part C, Pharmacology, Toxicology & Endocrinology. 121:1998;15-22.
40. Nikula H., Talonpoika T., Kaleva M., Toppari J. Inhibition of hCG-stimulated steroidogenesis in cultured mouse Leydig tumor cells by bisphenol A and octylphenols. Toxicology and Applied Pharmacology. 157:1999;166-173.
41. Olea N., Pulgar R., Perez P., Olea-Serrano F., Rivas A., Novillo-Fertrell A., Pedraza V., Soto A.M., Sonnenschein C. Estrogenicity of resin-based composites and sealants used in dentistry. Environmental Health Perspectives. 104:1996;298-305.
42. Olea N., Pazos P., Exposito J. Inadvertent exposure to xenoestrogens. European Journal of Cancer Prevention. 1:1998;S17-S23.
43. Ramos J.G., Varayoud J., Sommenschein C., Soto A.M., Munoz De Toro M., Luque E.H. Prenatal exposure of low doses of bisphenol A alters the periductal stroma and glandular cell function in the rat ventral prostate. Biology of Reproduction. 65:2001;1271-1277.
44. Ronco A.M., Valdés K., Marcus D., Llanos M. The mechanism for lindane-induced inhibition of steroidogenesis in cultured rat Leydig cells. Toxicology. 159:2001;99-106.
45. Routledge E.J., Sumpter J.P. Oestrogenic activity of surfactants and some of their degradation product assessed using a recombinant yeast screen. Environmental Toxicology and Chemistry. 15:1996;241-248.
46. Rudel R.A., Brody J.G., Spengler J.D., Vallarino J., Geno P.W., Sun G., Yau A. Identification of selected hormonally active agents and animal mammary carcinogens in commercial and residential air and dust samples. J. Air Waste Management Association. 51:2001;499-513.
47. Sanderson J.T., Seinen W., Giesy J.P., Slobbe L., van den Berg M. 2-Chloro-s-Triazine herbicides induce aromatase (CYP19) activity in H295R human adrenocortical carcinoma cells. a novel mechanism for estrogenicity? Toxicological Sciences. 54:2000;121-127.
48. Sanderson J.T., Boerma J., Lansbergen G.W., Safe S., van den Berg M. Induction and inhibition of aromatase (CYP19) activity by various classes of pesticides in H295R human adrenocortical carcinoma cells. Toxicology and Applied Pharmacology. 182:2002;44-54.
49. Séralini G.-E., Moslemi S. Aromatase inhibitors. past, present and future Molecular and Cellular Eendocrinology. 178:2001;117-131.
50. Simpson E.R., Mahendroo M.S., Means G.D., Kilgore M.W., Hinshelwood M.M., Graham-Lorence S., Amarneh B., Ito Y., Fisher C.R., Michael M.D., Mendelson C.R., Bulun S.R. Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis. Endocrinology Revue. 15:1994;342-355.
51. Sohoni P., Sumpter J.P. Several environmental oestrogens are also anti-androgens. Endocrinology. 158:1998;327-339.
52. Song K.H., Lee K., Choi H.S. Endocrine disrupter bisphenol A induces orphan nuclear receptor Nur77 gene expression and steroidogenesis in mouse testicular Leydig cells. Endocrinology. 143:2002;2208-2215.
53. Sonnenschein C., Soto A.M. An updated review of environmental estrogen and androgen mimics and antagonists. The Journal of Steroid Biochemistry and Molecular Biology. 65:1998;143-150.
54. Smith A.G. Chlorinated hydrocarbon insecticides. Hayes W.J., Laws E.R. Handbook of Pesticide Toxicology. 1991;731-915 Academic Press, New York.
55. Steinmetz R., Young P.C., Caperell-Grant A., Gize E.A., Madhukar B.V., Ben-Jonathan N., Bigsby R.M. Novel estrogenic action of the pesticide residue beta-hexachlorocyclohexane in human breast cancer cells. Cancer Research. 56:1996;5403-5409.
56. Takai Y., Tsutsumi O., Ikezuki Y., Kamei Y., Osuga Y., Yano T., Taketani Y. Preimplantation exposure to bisphenol A advances postnatal development. Reproductive Toxicology. 15:2001;71-74.
57. Takeuchi T., Tsutsumi O. Serum bisphenol A concentrations showed gender differences, possibly linked to androgen levels. Biochemical and Biophysical Research Communications. 291:2002;76-78.
58. Toda K., Miyaura C., Okada T., Shizuta Y. Dietary bisphenol A prevents ovarian degeneration and bone loss in female mice lacking the aromatase gene (Cyp19). European Journal of Biochemistry. 269:2002;2214-2222.
59. Tokunaga K., Nakamura Y., Sakata K., Fujimori K., Ohkubo M., Sawada K., Sakiyama S. Enhanced expression of a glyceraldehyde-3-phosphate dehydrogenase gene in human lung cancers. Cancer Research. 47:1987;5616-5619.
60. Toppari J., Larsen J.C., Christiansen P., Giwercman A., Grandjean P., Guillette L.J. Jr., JÈgou B., Jensen T.K., Jouannet P., Keiding N., Leffers H., McLachan J.A., Meyer O., Muller J., Rajpert-De Meyts L., Scheike T., Sharpe R., Sumpter J., Skakkebaek N.E. Male reproductive health and environmental xenoestrogens. Environmental Health Perspectives. 104:1996;741-803.
61. Vinggaard A.M., Hnida C., Breinholt V., Larsen J.C. Screening of selected pesticides for inhibition of CYP19 aromatase activity in vitro. Toxicology In Vitro. 14:2000;227-234.
62. Walsh L.P., Stocco D.M. Effects of lindane on steroidogenesis and steroidogenic acute regulatory protein expression. Biology of Reproduction. 63:2000;1024-1033.